EXTENSIVE STAGE SMALL CELL LUNG CANCER
Clinical trials for EXTENSIVE STAGE SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new EXTENSIVE STAGE SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for EXTENSIVE STAGE SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Double attack on deadly cancer: new trial aims to control aggressive tumors
Disease control Not yet recruitingThis study is testing whether combining two newer cancer drugs can help control aggressive small cell lung cancer and similar neuroendocrine cancers that have returned or stopped responding to standard treatments. The trial will enroll about 120 adults whose cancer has progressed…
Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for aggressive lung cancer: major trial launches
Disease control Not yet recruitingThis large Phase 3 trial will compare a new experimental drug, BL-B01D1, combined with an immunotherapy (tislelizumab) against the current standard platinum-based chemotherapy combined with the same immunotherapy. It aims to see if the new combination helps people with extensive-…
Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New combo therapy aims to keep aggressive lung cancer at bay
Disease control Not yet recruitingThis study is testing whether a combination of two drugs, lurbinectedin and durvalumab, can help control extensive-stage small cell lung cancer after initial chemotherapy. It is for patients whose cancer has not gotten worse after their first round of treatment. The main goal is …
Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
New hope for Tough-to-Treat lung cancer: experimental combo targets tumors two ways
Disease control Not yet recruitingThis study is testing whether combining two drugs, sacituzumab tirumotecan and anlotinib, can help control advanced small cell lung cancer in patients whose cancer has worsened after their initial immunotherapy and chemotherapy treatment. The trial will enroll about 30 adults to …
Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: China Medical University, China • Aim: Disease control
Last updated Mar 06, 2026 15:38 UTC
-
Doctors track lung cancer patients to unlock better treatment secrets
Knowledge-focused Not yet recruitingThis study aims to understand how patients with advanced small cell lung cancer respond to treatments in real hospital settings, not clinical trials. Researchers will observe 96 patients receiving standard care to learn which treatments work best and how safe they are in everyday…
Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CANCER
Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC